GlassScriptPhysician profile
Syed I Mobin
NPI 1689653479
$19,569.77
in general payments reported to CMS, 2019-2025
45 companies · $1,119 in 2025
The $1,119 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,093 · 2020: $2,205 · 2021: $569 · 2022: $4,843 · 2023: $5,708 · 2024: $4,033 · 2025: $1,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,769 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,988 · Consulting Fee: $2,100 · Travel and Lodging: $1,495 · Education: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,768.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,988.00 |
| Consulting Fee | $2,100.00 |
| Travel and Lodging | $1,495.01 |
| Education | $509.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $6,968.19 | 2019-2025 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $5,104.19 | 2019-2024 | |
| Glaxosmithkline, LLC. | $1,207.34 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,137.54 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Medical Device Business Services, INC. | $850.78 | 2023 | Na |
| Boehringer Ingelheim Pharmaceuticals, INC. | $622.15 | 2019-2025 | Ofev, Jascayd |
| Genzyme Corporation | $452.36 | 2020-2025 | |
| Philips North America LLC | $384.79 | 2019-2024 | (Ak6) Vest Therapy |
| Harmony Biosciences LLC | $325.91 | 2020-2025 | |
| Insmed, INC. | $319.58 | 2019-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $292.42 | 2019-2024 | Dupixent |
| Jazz Pharmaceuticals INC. | $199.02 | 2019-2025 | |
| Genentech USA, INC. | $167.13 | 2019-2025 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $149.67 | 2022-2025 | Glassia |
| Inspire Medical Systems, INC. | $146.70 | 2025 | Inspire |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $134.06 | 2019-2025 | |
| Ethicon INC. | $111.04 | 2024 | Monarch Platform |
| Merck Sharp & Dohme LLC | $101.59 | 2023-2025 | Winrevair |
| Electromed, INC. | $82.80 | 2023-2025 | Smartvest |
| United Therapeutics Corporation | $70.63 | 2019-2022 | |
| Pfizer INC. | $68.45 | 2019-2023 | |
| Vifor Pharma, INC. | $65.88 | 2024-2025 | Zemaira |
| Amgen INC. | $64.79 | 2022-2025 | Tezspire |
| Gilead Sciences, INC. | $63.14 | 2019-2022 | |
| Grifols USA, LLC | $59.44 | 2019-2023 | Prolastin-C Liquid |
| Portola Pharmaceuticals, LLC | $55.54 | 2019-2020 | |
| Baxter Healthcare | $45.80 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Mallinckrodt Hospital Products INC. | $37.50 | 2023 | Acthar |
| Intuitive Surgical, INC. | $35.00 | 2023 | Da Vinci Surgical System |
| Medtronic, INC. | $32.75 | 2021 | |
| Advanced Respiratory, INC | $27.78 | 2020 | |
| Vapotherm INC | $23.50 | 2023 | Vapotherm |
| Boston Scientific Corporation | $20.99 | 2023 | Acquire |
| Avadel Cns Pharmaceuticals, LLC | $19.09 | 2024 | Lumryz |
| Verona Pharma, INC. | $18.77 | 2025 | Ohtuvayre |
| Phadia US INC. | $18.61 | 2022 | |
| Pulmonx Corporation | $17.84 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Mylan Specialty L.P. | $14.23 | 2022 | |
| Ani Pharmaceuticals, INC. | $13.87 | 2024 | Purified Cortrophin Gel |
| E.R. Squibb & Sons, L.L.C. | $13.68 | 2022 | |
| Sunovion Pharmaceuticals INC. | $12.93 | 2019 | |
| Sandoz INC. | $12.30 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Mobin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.